drugset / Trial / NCT00003761
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This protocol is designed to evaluate the side effects of rV-DF3/MUC1 and to determine the safest dose which should be used in the treatment of breast cancer.
Timeline
- Start
- 1999-03-03
- Primary completion
- 2001-04-20
- Completion
- 2001-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MUC1 | Vaccine | 4.76e+06 unknown | Other |
| Subject | MUC1 | Vaccine | 4.76e+07 unknown | Other |
| Subject | MUC1 | Vaccine | 4.76e+08 unknown | Other |